← Back to Patent Explorer
US4526902A Expired / Lapsed US ⏱️ 0.0 years remaining

Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions

Assignee: Century Laboratories Inc
•
Filing: 1983-10-24
•
Granted: 1985-07-02
•
Expires: 2003-10-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Treatment of prophylaxis of thrombo-embolic conditions is obtained through the simultaneous administration of eicosapentaenoic acid and/or docosahexaenoic acid together with one or more of linoleic acid, γ-linolenic acid and dihomo-γ-linolenic acid, either in the form of a pharmaceutical dosage or in the form of a food product such as margarine or cooking oil.

Inventors

  • 👤 David Rubin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 15:39
CPC Classifications
C; C11; C11C; C11C1/00; C11C1/02; C11C1/025; A; A23; A23D; A23D7/00; A23D7/005; A23D7/0056; A23D9/00; A23D9/007; A23L; A23L33/00; A23L33/10; A23L33/115; A23L33/12; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61K31/20; A61P; A61P3/00; A61P3/06; C07; C07C; C07C51/00; C07C51/42; C07C51/487; C07C57/00; C07C57/02; C07C57/03; C11C1/005; A23V; A23V2002/00

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 76 words
A pharmaceutical composition for treatment or prophylaxis of thrombo-embolic conditions consisting essentially of an effective amount of a combination of a first component selected from the group consisting of 5, 8, 11, 14, 17-eicosapentaenoic acid, 22:6 ω 3-docosahexaenoic acid and a combination thereof, and a second component selected from the group consisting of linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid and combinations thereof, said first and second components being present in relative amounts of 3:1 to 1:3.
Claim 2
Dependent Claim 76 words
A pharmaceutical composition for treatment or prophylaxis of thrombo-embolic conditions consisting essentially of an effective amount of a combination of a first component selected from the group consisting of 5, 8, 11, 14, 17-eicosapentaenoic acid, 22:6 ω 3-docosahexaenoic acid and a combination thereof, and a second component selected from the group consisting of linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid and combinations thereof, said first and second components being present in relative amounts of 3:1 to 1:3.
Claim 3
Dependent Claim 13 words
A composition in accordance with claim 1, further includng a pharmaceutically acceptable excipient.
Claim 4
Dependent Claim 18 words
A composition in accordance with claim 1, wherein said composition is substantially free of other unsaturated fatty acids.
Claim 5
Dependent Claim 87 words
In a food product containing a substantial amount of at least one fatty acid, the improvement wherein said at least one fatty acid present in said food product consists essentially of a combination of a first component selected from the group consisting of 5,8,11,14,17-eicosapentaenoic acid, 22:6 ω 3 docosahexaenoic acid and a combination thereof, and a second component selected from the group consisting of linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid and combinations thereof, said first and second components being present in relative amounts of 3:1 to 1:3.
Claim 6
Dependent Claim 87 words
In a food product containing a substantial amount of at least one fatty acid, the improvement wherein said at least one fatty acid present in said food product consists essentially of a combination of a first component selected from the group consisting of 5,8,11,14,17-eicosapentaenoic acid, 22:6 ω 3 docosahexaenoic acid and a combination thereof, and a second component selected from the group consisting of linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid and combinations thereof, said first and second components being present in relative amounts of 3:1 to 1:3.
Claim 7
Dependent Claim 14 words
A food product in accordance with claim 4, wherein said food product is margarine.
Claim 8
Dependent Claim 14 words
A composition in accordance with claim 1, wherein said first component is 5,8,11,14,17-eicosapentaenoic acid.
Claim 9
Dependent Claim 14 words
A composition in accordance with claim 6, wherein said second component is linoleic acid.
Claim 10
Dependent Claim 15 words
A food product in accordance with claim 4, wherein said first component is 5,8,11,14,17-eicosapentaenoic acid.
Claim 11
Dependent Claim 15 words
A food product in accordance with claim 8, wherein said second component is linoleic acid.

References Cited (Backward Citations)

GB1082624A Cited
US4097602A Cited
GB2033745A Cited
GB1604554A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-01 1988-12-31 1989-07-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-01 1992-12-31 1993-07-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-01 1996-12-31 1997-07-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag